| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2007 | CN101040904A Drug for scald and its preparing method |
| 09/26/2007 | CN101040903A Farinfrared emplastrum |
| 09/26/2007 | CN101040897A Medicine compound for preventing and treating gynecopathy such as pelvic inflammatory disease |
| 09/26/2007 | CN101040895A Medicine for improving immunity |
| 09/26/2007 | CN101040893A Blueberry capsule for protecting vision and the preparing method |
| 09/26/2007 | CN101040888A Acne treating medicine |
| 09/26/2007 | CN101040886A Medicine compound of erigeron breviscapus and tanshinone IIA sodium sulfoacid |
| 09/26/2007 | CN101040885A Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin |
| 09/26/2007 | CN101040883A Andrographis root extraction and its preparing process and application |
| 09/26/2007 | CN101040874A Compound medicine took orally for treating osteoporosis |
| 09/26/2007 | CN101040870A Solution for eliminating callus |
| 09/26/2007 | CN101040869A Nanometer elemental selenium coupled with liquid amino acid and the method for preparing and preserving the same |
| 09/26/2007 | CN101040867A Application of fucoidan in the preparation of medicine and health-care products for preventing and treating neurodegenerative diseases |
| 09/26/2007 | CN101040866A Application of flyblow chitosan in the preparation of products for regulating blood lipid |
| 09/26/2007 | CN101040865A Sustained-released injection including antimetabolite medicine and alkylate agent |
| 09/26/2007 | CN101040864A Application of paeoniflorin for enriching the blood |
| 09/26/2007 | CN101040863A Chinese traditional medicine monocase compound for treating alzheimers disease |
| 09/26/2007 | CN101040862A Application of gastrodin in the medicine for treating rheumatoid arthritis |
| 09/26/2007 | CN101040861A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkylate agent |
| 09/26/2007 | CN101040860A Pharmaceutical composition for treatment of lower urinary tract diseases |
| 09/26/2007 | CN101040859A Anticancer compound including anticancer medicine and the synergistic agent |
| 09/26/2007 | CN101040858A Anticancer compound including taxanes and alkylate agent |
| 09/26/2007 | CN101040857A Intranasal pharmaceutical preparation for treating vomit caused by cancer chemo-treatment, radiation-treatment or operation |
| 09/26/2007 | CN101040856A Compound agent including moxifloxacin and pidotimod |
| 09/26/2007 | CN101040855A Compound including rimonabant and poloxamer, solid dispersion and the preparation and the application of the medicine |
| 09/26/2007 | CN101040854A Method of treatment of diabetes with a combination of a thiazolidinedione and metformin |
| 09/26/2007 | CN101040853A Bulleyaconitine multilocular liposomes and the method of preparing the same |
| 09/26/2007 | CN101040852A Sustained-released injection including platinum compound and the alkylate agent |
| 09/26/2007 | CN101040851A The use of dicaffeoylguinic acid ramification and the analog in the treatment of diabetes and the corresponding disease |
| 09/26/2007 | CN101040850A Colchicine sustained-release pellets and the preparing method |
| 09/26/2007 | CN101040848A Method for preparing amphiphilic nanoparticles |
| 09/26/2007 | CN101040847A Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same |
| 09/26/2007 | CN101040846A Nonoxinol foaming agent and the method of preparing the same |
| 09/26/2007 | CN101040845A Nonoxinol foaming agent and the method of preparing the same |
| 09/26/2007 | CN101040844A Anticancer compound including alkylate agent and epothilones |
| 09/26/2007 | CN101040843A Solid tumor resisting release agent including nimustine and the intensifier |
| 09/26/2007 | CN101040842A Sustained-released injection including phosphatidylinostitol 3-kinase inhibitor and platinum compound |
| 09/26/2007 | CN101040841A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkaloid |
| 09/26/2007 | CN101040840A Anticancer compound including taxanes and phosphatidylinostitol 3-kinase inhibitor |
| 09/26/2007 | CN101040839A Anticancer compound carrying phosphatidylinostitol 3-kinase inhibitor and the synergistic agent thereof |
| 09/26/2007 | CN101040838A Anticancer compound including phosphatidylinositol 3-kinase inhibitor and alkylate |
| 09/26/2007 | CN101040837A Itracomazole cream and the method for preparing the same |
| 09/26/2007 | CN101040733A Glove for relieving itch and inflammation, and method for producing the same |
| 09/26/2007 | CN101040712A Compound containing DAG and the method for preparing the same |
| 09/26/2007 | CN101040647A Mulberry leaf tea and its preparing process |
| 09/26/2007 | CN100339477C Methods and devices for tissure repair |
| 09/26/2007 | CN100339415C Polymer guanidine derivatives as a cytostatic medicament |
| 09/26/2007 | CN100339389C 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 09/26/2007 | CN100339384C Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof |
| 09/26/2007 | CN100339383C Medication towards target of bone, synthetic method and application |
| 09/26/2007 | CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 09/26/2007 | CN100339378C 6-2-(2-halogen-4-alkoxypenyl)-triazo-pyrimidine of killing fungus |
| 09/26/2007 | CN100339377C Camptothecine derivative and its preparation |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339375C Metabolites of ecteinascidin 743 |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339373C Paclitaxel analogs, preparation and use as antitumor agents |
| 09/26/2007 | CN100339356C Aminoadamantane derivatives as therapeutic agents |
| 09/26/2007 | CN100339353C Preparation method and use of alpine yarrow herb ketoacid |
| 09/26/2007 | CN100339097C Compound ointment for treating acne |
| 09/26/2007 | CN100339094C Formula of medicine for preventing and curing coccidiosis of chicken |
| 09/26/2007 | CN100339087C External medicine for treating wart, helosis and callosity |
| 09/26/2007 | CN100339086C Medicine for preventing oral cavity cancer and its prepn |
| 09/26/2007 | CN100339085C Combination of Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| 09/26/2007 | CN100339084C Fosfocina calcium disperser, and its prepn. method |
| 09/26/2007 | CN100339083C Progesterone liquid capsule and its preparation method |
| 09/26/2007 | CN100339082C Terazosin hydrochloride dripping pills, and its prepn. method |
| 09/26/2007 | CN100339081C Oral loratadine disintegrating tablet and its prepn |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/26/2007 | CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 09/26/2007 | CN100339078C Solid drug for oral use |
| 09/26/2007 | CN100339077C New use of indole derivatives as anti-SARS medicine |
| 09/26/2007 | CN100339076C Indapamide dripping pills, and its prepn. method |
| 09/26/2007 | CN100339075C Hair and nail treatments using alkanolamines |
| 09/26/2007 | CN100339074C New application of isoflavone of soybean |
| 09/26/2007 | CN100339073C Aryl sulfonamides as serotonin antagonist for treatment of obesity |
| 09/26/2007 | CN100339072C Methocarbamol dry mixing suspension |
| 09/26/2007 | CN100339071C Application of diacyl thiourea derivative in preparing antiviral medicine |
| 09/26/2007 | CN100339069C Formulation comprising thymol useful in treatment of drug resistant bacterial infections |
| 09/25/2007 | USRE39862 Unsaturated 14, 15-cyclopropanoandrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/25/2007 | USRE39861 Methods of extended use oral contraception |
| 09/25/2007 | US7273952 Substituted C-cyclohexylmethylamine derivatives |
| 09/25/2007 | US7273947 Method for reducing 3-dimethylamnio-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 09/25/2007 | US7273946 Nitroxy derivatives, e.g., 4-(nitrooxy)butyl [1R-[1 alpha (Z),2 alpha (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenoate; used for the treatment of glaucoma and ocular hypertension |
| 09/25/2007 | US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 09/25/2007 | US7273932 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273890 ST104P, an anti-angiogenic agent |
| 09/25/2007 | US7273889 Administering ketamine in mixture with carrier; side effect reduction |
| 09/25/2007 | US7273888 Administrating inhibitors of ornithine decarboxylase (involved with synthesis of putrescine; antiproliferative agents |
| 09/25/2007 | US7273887 Procaine, lidocaine, tetracaine or salts thereof; and a skin penetration enhancer in an anhydrous solution, and a volatile co-solvent; allows for a lesser total dosage resulting in decreased systemic toxicity. |
| 09/25/2007 | US7273886 Benzofuran inhibitors of factor VIIa |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273884 Method of treating tremors |
| 09/25/2007 | US7273883 Prostaglandin EP4 antagonist |
| 09/25/2007 | US7273882 Aminoacetamide acyl guanidines as β-secretase inhibitors |
| 09/25/2007 | US7273881 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 09/25/2007 | US7273880 Selective NPY (Y5) antagonists |
| 09/25/2007 | US7273877 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives |